National Cabinet is meeting today to discuss hospital funding, and the interconnected issues of NDIS reform and GST allocation. But how are hospitals actually funded? And what’s GST got to do with it?
Articles on Health economics
Displaying 41 - 60 of 271 articles
Eating too much salt is bad for our health. Governments and food manufacturers have a big role to play in reducing the salt content of Australians’ diets.
Yes, savings from increased participation in private insurance outweigh the costs the government incurs by subsidising private health insurance rebates. But rebates can be better targeted.
We found rebates don’t do much to encourage older people to sign up for private health insurance.
A new review of Australian health care workers’ scope of practice should focus on expanding pharmacists prescribing for stable conditions and long-term medications, under the direction of a GP.
Governments spend billions of dollars every year to encourage us to take up private cover. But our research shows this does little to reduce pressure on the public system.
A social insurance model would use compulsory contributions from worker salaries to cover the cost of aged care services. But it’s not a silver bullet to fix our aged-care funding crisis.
People on higher incomes without private health insurance don’t seem to be swayed by financial incentives, our research shows.
A gap between rich and the poor in cancer deaths for middle-aged people is growing. Deaths from cancer have fallen over time, but less so in our poorest regions where there is less health care access.
One proposal to fund the rising costs of aged care is a Medicare-style levy. However, this seemingly neat solution isn’t the answer to our aged care funding problems. Here’s why.
Aged care is one of the government’s biggest ongoing funding challenges. But for a sustainable system, we need to ensure everyone is paying their fair share. Here’s how to make it more equitable.
MyMedicare is a new voluntary scheme that allows patients to register with their usual GP. How will it work? And how might it benefit patients? Here’s what we know so far.
The big news on budget night was a tripling of the bulk-billing incentive. It’s hoped to stem the decline in bulk billing – but it’s unclear if it will increase it.
The new reforms tackle some of the biggest challenges in general practice: outmoded technology, GPs working with little support, a broken funding model and restrictive regulations.
The Pharmacy Guild head wept at the thought of pharmacies losing income from a change that allows people with chronic diseases to halve their prescription costs. What’s going on?
In Australia’s bulk-billing ‘deserts’, it’s incredibly difficult to find a doctor who will bulk bill. The government should step in to support or set up clinics so locals have access to health care.
Medicare access could be restricted to GPs who agree to bulk bill all patients, while allowing those who don’t bulk bill to rely solely on out-of-pocket payments.
A new Grattan report recommends making general practice a team sport, using the skills of other clinicians and health-care workers.
Three out of five said yes.
The budget forecast steep NDIS costs, but also allocated funds to review and support the scheme in sustainable ways that could contribute positively to the economy.
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor and Director, Macquarie University Centre for the Health Economy, Macquarie University
-
Professor of Health Economics, The University of Melbourne
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Professor of Health Economics, Flinders University
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Health economist, University of Sydney
-
Professor, Public Service Research, UNSW Sydney
-
Senior Policy Adviser, National Rural Health Alliance; Adjunct Lecturer, University of Sydney
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Lecturer, Public Sector Finance, University of Canberra
-
Senior lecturer, Economics Department, University of Technology Sydney
